MAPT and dementia: Although higher toxic potential is actually attributed to Aβ-derived diffusible ligands (ADDLs) and not to insoluble forms of Aβ [177], tau is considered decisive for the progression of neurodegeneration [178], and the spreading of the tau pathology in affected individuals correlates well with memory impairment and dementia symptoms [179].